• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland.

作者信息

Hayward J L, Rubens R D, Carbone P P, Heuson J C, Kumaoka S, Segaloff A

出版信息

Eur J Cancer (1965). 1978 Nov;14(11):1291-2. doi: 10.1016/0014-2964(78)90238-4.

DOI:10.1016/0014-2964(78)90238-4
PMID:738335
Abstract
摘要

相似文献

1
Assessment of response to therapy in advanced breast cancer. A project of the programme on clinical oncology of the International Union against Cancer, Geneva, Switzerland.
Eur J Cancer (1965). 1978 Nov;14(11):1291-2. doi: 10.1016/0014-2964(78)90238-4.
2
Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.晚期乳腺癌治疗反应评估：瑞士日内瓦国际抗癌联盟临床肿瘤学项目。
Cancer. 1977 Mar;39(3):1289-94. doi: 10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f.
3
Assessment of response to therapy in advanced breast cancer (an amendment).晚期乳腺癌治疗反应评估（修订案）
Br J Cancer. 1978 Jul;38(1):201. doi: 10.1038/bjc.1978.182.
4
The EORTC Breast Cancer Group: 40 years of research contributing to improve breast cancer management.欧洲癌症研究与治疗组织乳腺癌小组：40年研究助力改善乳腺癌治疗
Eur J Cancer. 2002 Mar;38 Suppl 4:S39-43. doi: 10.1016/s0959-8049(01)00450-6.
5
Letter: Assessment of response to treatment in advanced breast cancer.信函：晚期乳腺癌治疗反应评估
Lancet. 1974 Aug 24;2(7878):465. doi: 10.1016/s0140-6736(74)91847-9.
6
[Project of a program for the estimation of efficacy of treatment of patients with far-advanced forms of breast cancer].[晚期乳腺癌患者治疗效果评估项目方案]
Vopr Onkol. 1977;23(9):8-12.
7
Problems in hormonal therapy for advanced breast cancer.晚期乳腺癌激素治疗中的问题。
Prog Clin Biol Res. 1977;12:467-77.
8
Breast Surgery International--breast cancer in developing countries.《国际乳腺外科》——发展中国家的乳腺癌
Scand J Surg. 2002;91(3):222-6. doi: 10.1177/145749690209100302.
9
[Bilateral adrenalectomy for advanced breast cancer].[双侧肾上腺切除术治疗晚期乳腺癌]
Harefuah. 1976 May 2;90(9):431-5.
10
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).ESO-ESMO 第 3 版年轻女性乳腺癌国际共识指南（BCY3）。
Breast. 2017 Oct;35:203-217. doi: 10.1016/j.breast.2017.07.017. Epub 2017 Aug 17.

引用本文的文献

1
Expression of CXCR4 in the Primary Lesion of Recurrent Metastatic Breast Cancer and Its Association With Prognosis.CXCR4在复发性转移性乳腺癌原发灶中的表达及其与预后的关系。
Int J Gen Med. 2025 Mar 18;18:1543-1553. doi: 10.2147/IJGM.S511426. eCollection 2025.
2
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer.原发性乳腺癌中 ESR1 融合基因转录本的预后和预测价值。
BMC Cancer. 2022 Feb 12;22(1):165. doi: 10.1186/s12885-022-09265-1.
3
Longitudinal analysis of bone metabolism using SPECT/CT and (99m)Tc-diphosphono-propanedicarboxylic acid: comparison of visual and quantitative analysis.
使用SPECT/CT和（99m）锝-二膦酰基丙烷二羧酸对骨代谢进行纵向分析：视觉分析与定量分析的比较
EJNMMI Res. 2016 Dec;6(1):60. doi: 10.1186/s13550-016-0217-4. Epub 2016 Jul 28.
4
Association of thymidylate synthase expression and clinical outcomes of gastric cancer patients treated with fluoropyrimidine-based chemotherapy: a meta-analysis.胸苷酸合成酶表达与接受氟嘧啶类化疗的胃癌患者临床结局的相关性：一项荟萃分析。
Onco Targets Ther. 2016 Mar 9;9:1339-50. doi: 10.2147/OTT.S98540. eCollection 2016.
5
Functional magnetic resonance: biomarkers of response in breast cancer.功能磁共振：乳腺癌反应的生物标志物。
Breast Cancer Res. 2011 Feb 23;13(1):204. doi: 10.1186/bcr2815.
6
Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.血管内皮生长因子受体 1、2 和 3 的表达对胃癌患者预后的影响。
Cancer Sci. 2009 Feb;100(2):310-5. doi: 10.1111/j.1349-7006.2008.01020.x.
7
Mistletoe therapy in oncology.肿瘤学中的槲寄生疗法。
Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD003297. doi: 10.1002/14651858.CD003297.pub2.
8
Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.切除修复交叉互补基因1（ERCC1）、二氢嘧啶脱氢酶及表皮生长因子受体对晚期胃癌患者预后的影响
Br J Cancer. 2008 Feb 26;98(4):832-9. doi: 10.1038/sj.bjc.6604211. Epub 2008 Jan 29.
9
Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer.局部晚期乳腺癌新辅助蒽环类化疗反应的临床和病理预测因素
Med Oncol. 2006;23(2):171-83. doi: 10.1385/MO:23:2:171.
10
Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer.伊立替康联合S-1治疗胃癌可克服胸苷酸合成酶的预测能力。
Br J Cancer. 2004 Oct 4;91(7):1245-50. doi: 10.1038/sj.bjc.6602139.